Analysts estimate that Merck & Co will report an earnings per share (EPS) of $2.01. Investors in Merck & Co are eagerly ...

We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Merck & Co., Inc. stands seventh on our list and recently ...

Science does not support aluminum as a culprit of autism. Yet RFK Jr. and his associates continue to find ways to support the ...

Merck & Co., Inc. (NYSE:MRK) is one of the top low volatility healthcare stocks to buy now. Analyst Daina Graybosch of ...

The startup is using elements of gene and cell therapy to create medicines that could be useful against an array of ...

India], July 28: Merck Foundation, the philanthropic arm of Merck KGaA Germany, marks ‘World ART (Assisted Reproductive ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has ...

A cancer vaccine developed by Moderna Inc. and Merck & Co. Inc. showed promising results in a key study, reducing the risk of recurrence or death by 44%.

The pharmaceutical industry has a fresh sense of direction after President Donald Trump’s tax-and-spending law included a ...

COPENHAGEN, Denmark, July 25, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will be presenting two-year ...

Amphista Therapeutics has achieved a discovery research milestone in its collaboration and licence agreement with Merck. The ...

Cambridge biotechnology company Amphista Therapeutics has clinched an unspecified milestone payment from its research collaboration with Merck. The target that has triggered the payment also remains ...